Meeting
2018 ASCO Annual Meeting
Feasibility of perioperative multi-gene panel testing (MGPT) in cancer patients eligible for hereditary genetic evaluation (GE): The PROTECT pilot.
Authors
Michael J. Hall
Fox Chase Cancer Center, Philadelphia, PA
Michael J. Hall , Elizabeth A. Handorf , Andrea Forman , Yana Chertock , Elias Obeid , Mary Beryl Daly
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 36, 2018 (suppl; abstr 1536)
DOI
10.1200/JCO.2018.36.15_suppl.1536
Abstract #
1536
Poster Bd #
107
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Somatic profiling guides germline genetic testing in patients with mutations in cancer predisposition genes.
First Author: Sourat Darabi
Poster
2021 ASCO Annual Meeting
Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types.
First Author: Kristen Hanson
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Pathogenic variants among Mexican patients with colorectal cancer referred for genetic cancer risk assessment.
First Author: Jose Luis Rodriguez Olivares
Poster
2021 ASCO Annual Meeting
High prevalence of actionable germline variants in unselected endometrial cancer (EC) patients.
First Author: Monica Levine